Company Data
IN8bio Inc.
Ticker
INAB
Current Price
$0.3378 -28.88%
Market Cap
$15.8M
Price Target
Refer to Report
Volume
3.1M
52wk Range
$0.217 - $2.48
Overview
IN8bio Inc is a clinical-stage biotechnology company. It is focused on developing innovative therapies for the treatment of cancers, including solid tumors, by employing allogeneic, autologous and genetically modified gamma-delta T cells.